Non-small-cell lung cancer (NSCLC) is the most common type of cancer affecting the lungs. The diverse types of NSCLC are characterized by cancer cells that grow and spread in different ways. The three ...
HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...
A Phase 3 trial of firmonertinib did not meet its main goal in a hard-to-treat lung cancer subtype, though the drug caused ...
Target high-unmet-need niches—post-immunotherapy resistance, rare biomarkers and early-stage disease—while tracking therapy uptake, pricing and market access.Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- ...
A diagnosis of advanced non-small-cell lung cancer (NSCLC) can bring a lot of questions. The FDA approved Jideytro (zidesamtinib) in 2026. It belongs to a group of medicines known as kinase inhibitors ...
MedPage Today on MSN
Chemo-Free Regimen May Be Effective Option for EGFR-Mutant Lung Cancer
Phase II study shows promise in setting of third-generation EGFR TKI resistance ...
ROS1-positive non-small cell lung cancer (NSCLC) is a rare subtype of lung cancer that occurs when part of the ROS1 gene fuses with another gene. It affects about 1% to 2% of people with NSCLC and ...
A diagnosis of non-small cell lung cancer (NSCLC) can significantly affect emotional health, leading to mental health challenges such as depression, anxiety, and distress. Comprehensive mental health ...
HotCopper on MSN
Racura greenlit to increase dose of RC220 for one patient in ongoing lung cancer combo treatment trial
Racura Oncology (ASX:RAC) has been greenlit by a safety committee to increase to 100mg the dose of its novel RC220 drug for ...
Enrollment completed in Part C of THIO-101 Phase 2 study; 65% of 2026 enrollment target reached in pivotal THIO-104 Phase 3 ...
The Business Research Company's Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Non-Small Cell Lung Cancer (NSCLC) Global Market ...
ROS1-positive non-small cell lung cancer (NSCLC) is a rare lung cancer subtype occurring when part of the ROS1 gene fuses with another gene. Affecting around 1% to 2% of people with NSCLC, it tends to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results